Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2025 · career development · Career Development Award
Pilot Study of a Cardiorespiratory Exercise Intervention During Immune Checkpoint Inhibitor Therapy in Early StageTriple Negative Breast Cancer
Jasmine Sukumar · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2025 · career development · Young Investigator Award
Delineating the Function and Prognostic Value of Soluble Oncostatin M Receptor (sOSMR) in Acute Myeloid Leukemia (AML)
Jennifer Marvin-Peek · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2025 · career development · Young Investigator Award
Assessing the Feasibility of Molecular Subtyping with an Integrated WES/RNASeq Assay for Peripheral T cell Lymphoma (PTCL) and Validation of PTCL Subtypes
Neha Akkad · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2025 · career development · Young Investigator Award
Combining IL-12-Expressing Oncolytic HSV1 with TGF-β and Corticosteroid-Resistant Natural Killer Cells to Target Glioblastoma
Hila Shaim · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2025 · research · BCRF-AACR CDA to Promote Diversity and Inclusion
Defining the Role of LRRC17+ CAFs in the Breast Tumor Microenvironment
Fernanda G. Kugeratski · The University of Texas MD Anderson Cancer Center · funded by American Association for Cancer Research
2025 · training · HIP Fellow Award
HIP Fellow Award 2025: Eduardo Edelman Saul
Eduardo Edelman Saul · The University of Texas MD Anderson Cancer Center · funded by American Society of Hematology
2025–2027 · contract · N01
Project Title: Low-dose erlotinib and mesalamine for prevention of colitis-associated colorectal cancer (CAC)
Eduardo Vilar Sanchez · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · career development · K23
Hyperpolarized Xenon-129 MRI as a predictive biomarker for mitigating radiation-induced lung injury
Joshua Niedzielski · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · research · R01
Detection and elimination of drug tolerant persister cells in small cell lung cancer
Carl Michael Gay · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2027 · research · R03
Investigation of the cell of origin and evolutionary trajectories of human glioblastoma
Luigi Perelli · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2029 · research · R01
Single-use Microfluidic Device for Radiopharmaceutical Production
Leon Marcel Bellan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2029 · research · R01
Deciphering the role of GFPT2 in radiation-induced cardiovascular disease
Jun-Ichi Abe · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · research · R01
RISE: Reducing Cancer and HIV Stigma through Empowerment
Qian Lu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2027 · research · R21
Proteomics-driven precision molecular mapping of patient tumors to preclinical models in lung cancer
Luc Girard · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · research · R01
Endogenous Circular RNAs limit abemaciclib anti tumor immune responses
Jlenia Guarnerio · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · research · R01
Harvard MD Anderson Collaborative to Reduce LyMphatic MOrbidity in Head and Neck Cancer with Artificial Intelligence (HARMONiC-AI)
Clifton David Fuller · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · research · R01
Study of a new driver and therapeutic vulnerability of bone metastasis
Li Ma · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2027 · cooperative agreement · UG3
Chimeric RNA driven neopeptide vaccine for prevention of breast cancer in germline BRCA1/2 carriers
Isabelle Bedrosian · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2027 · research · R21
Targeting a Novel Secreted Immune Checkpoint to Enhance Liver Cancer Immunotherapy
Yalan Deng · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2027 · research · R21
IL13Ra2-targeted radioimmunotherapy for glioblastoma
Simone Krebs · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2028 · fellowship · F31
Investigating the role of CARM1-mediated methylation of Qki in glioblastoma
Kaylene Jiayi Lu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · program · P01
InHANCE: Imaging Innovation for Head And Neck Cancer Evaluation & Treatment Delivery
Kristy Brock · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · research · R37
Together stronger: A family-centered lifestyle intervention for Black prostate cancer survivors and their caregivers
Dalnim Cho · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2027 · research · R21
Investigating the impact of glioma-associated germline risk alleles on neurodevelopmental trajectories
Jason Huse · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · research · R01
Deciphering the structural determinants of response and resistance to HER2-targeted antibody-drug conjugates and tyrosine kinase inhibitors for HER2-mutant Non-Small Cell Lung Cancer
John V. Heymach · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2027 · research · R21
Pan-cancer Analysis of Convergent Immunoglobulins from Tumor-infiltrating B Cells
Bin Liu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · research · R01
Role of targeting ATPases BRG1/BRM in therapy of AML
Kapil Bhalla · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · research · R01
RISE: Reducing Cancer and HIV Stigma through Empowerment
Qian Lu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2029 · research · R35
Computational and experimental approaches for decoding the function and regulation of unconventional RNA translation
Yiwen Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · research · R01
RISE: Reducing Cancer and HIV Stigma through Empowerment
Qian Lu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · career development · K01
When molds go viral: Dissecting the pathogenesis of post-viral Aspergillus pneumonias to guide immunomodulatory therapy in immunocompromised hosts
Sebastian Thomas Wurster · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · program · P01
InHANCE: Imaging Innovation for Head And Neck Cancer Evaluation & Treatment Delivery
Kristy Brock · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · research · R01
Machine learning for identifying antigen-antibody interactions from massive sequencing data
Junzhou Huang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2028 · fellowship · F32
Evolution and clinical significance of complex genome rearrangements
Andrew Lynch · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2026 · career development · K99
Adverse gut microbiome promotes resistance immune checkpoint inhibitors via chronic inflammation
Erez N Baruch · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2027 · research · R21
Exploratory studies of cellular resistance to MTA-cooperative PRMT5 inhibitors in MTAP-loss tumors.
Jordi Rodon Ahnert · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2027 · research · R03
Dissecting clonal determinants of platinum/PARP inhibitor cross-resistance in ovarian cancer
Francesca Citron · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · research · R01
Reversing effector-to-memory transition at ARTi to impact the HIV reservoir towards ART-free control
Elena Martinelli · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · cooperative agreement · U54
Lymphoma Outcomes SPORE
Christopher R Flowers · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2027 · research · R37
Expansion of Tumoroid Models for Precise Treatment of the Rectal Cancer Patient
Jesse Joshua Smith · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
